Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro

Endocrinology

Volumn 137, Issue 8, 1996, Pages 3163-3169

  Kawakami, Atsushi ^a   Eguchi, Katsumi ^a   Matsuoka, Naoki ^a   Tsuboi, Masahiko ^a   Kawabe, Yojiro ^a   Ishikawa, Naofumi ^a,b   Ito, Kunihiko ^a,b   Nagataki, Shigenobu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b ITO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FAS ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; THYROTROPIN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTO ONCOGENE; THYROID CELL;

EID: 0029941662     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.8.8754734     Document Type: Article

References (42)

1. Dumont JE 1971 The action of thyrotropin on thyroid metabolism. Vitam Horm 29:376-377
2. Westermark B, Karlsson FA, Walinder O 1979 Thyrotropin is not a growth factor for human thyroid cells in culture. Proc Natl Acad Sci USA 76:2022-2026
3. Wadeleux PA, Winard RJ 1981 Some unexpected effects of thyrotropin on the metabolism of thyroid cells isolated from non-toxic goitre. Acta Endocrinol (Copenh) 98:533-539
4. Valente WA, Vitti P, Kohn LD, Brandi ML, Rotella CM, Toccafondi R, Tramontano D, Aloj SM, Ambesi-Impiombato FS 1983 The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. Endocrinology 112:71-79
5. Rittmaster RS, Magor KE, Manning AP, Norman RW, Lazier CB 1991 Differential effect of 5α-reductase inhibition and castration on androgen-regulated gene expression in rat prostate. Mol Endocrinol 5:1023-1029
6. Kyprianou N, Isaacs JT 1988 Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552-562
7. Mahmoud I, Colin I, Many MC, Denef JF 1986 Direct toxic effect of iodide in excess on iodide-deficient thyroid glands: epithelial necrosis and inflammation associated with lipofuscic accumulation. Exp Mol Pathol 44:259-271
8. Tanimoto C, Hirakawa S, Kawasaki H, Hayakawa N, Ota Z 1995 Apoptosis in thyroid diseases: a histochemical study. Endocr J 42:193-201
9. Dremier S, Golstein J, Mosselmans R, Dumont JE, Galand P, Robaye B 1994 Apoptosis in dog thyroid cells. Biochem Biophys Res Commun 200:52-58
10. Ito N, Yonehara S, Ishii A, Yanahara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S 1991 The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243
11. Mysler E, Bini P, Drappa J, Ramos P, Friedman SM, Krammer PH, Elkon KB 1994 The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 93:1029-1034
12. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K 1995 Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38:485-491
13. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A 1994 Anti-Fas/Apo-1 antibody-mediated apoptosis of cultured human glioma cells: induction and modulation of sensitivity by cytokines. J Clin Invest 94:954-964
14. Ito N, Tsujimoto Y, Nagata S 1993 Effect of Bcl-2 on Fas antigen-mediated cell death. J Immunol 151:621-627
15. Allsopp TE, Wyatt S, Paterson HF, Davies AM 1993 The proto-oncogene Bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73:295-307
16. Nunez G, London L, Hockenbery D, Alexander M, Mckearn JP, Korsmeyer SJ 1990 Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602-3610
17. Oltvai ZN, Milliman CL, Korsmeyer SJ 1993 Bcl-2 heterodimerized in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619
18. Berchem GJ, Bosseler M, Vencia La Sugar Y, Voeller HJ, Zeitlin S, Gelmann EP 1995 Androgens induce resistance to Bcl-2-mediated apoptosis in LNCaP prostate cancer cells. Cancer Res 55:735-738
19. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R 1993 Detection of the apoptosis-suppressing oncoprotein Bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 143:390-400
20. Matsunaga M, Eguchi K, Fukuda T, Kurata A, Tezuka H, Shimomura C, Otsubo T, Ishikawa N, Ito K, Nagataki S 1986 Class II major histocompatibility complex antigen expression and cellular interaction in thyroid glands of Graves' disease. J Clin Endocrinol Metab 62:723-728
21. + lymphocytes. J Immunol 144:574-582
22. Nicoletti I, Migliorati G, Pagliacci MC, Riccardi C 1991 A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279
23. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P 1991 A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 67:629-639
24. Kawakami A, Tian Q, Duan X, Streuli M, Schlossman SF, Anderson P 1992 Identification and functional characterization of a TIA-1-related nucleolycin. Proc Natl Acad Sci USA 89:8681-8685
25. Field JB 1991 Mechanism of action of thyrotropin. In: Braverman LE, Utiger RD (eds) The Thyroid, ed 6. J. B. Lippincott Company, Philadelphia, pp 277-278
26. Martin A, Huber GK, Davis TF 1990 Induction of human thyroid cell ICAM-1 (CD54) antigen expression and ICAM-1-mediated lymphocyte binding. Endocrinology 127:651-657
27. Richardson BC, Lalwani ND, Johnson KJ, Marks RM 1994 Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol 24:2640-2645
28. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ 1990 Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-338
29. Aiello A, Delia D, Borrello MG, Biassoni D, Giardini R, Fontanella E, Pezzella F, Pulford K, Pierotti M, Porta GD 1992 Flow cytomeric detection of the mitochondrial Bcl-2 protein in normal and neoplastic human lymphoid cells. Cytometry 13:502-509
30. Martin DP, Schmidt RE, DiStefano PS, Lowry OH, Carter JG, Johnson Jr EM 1988 Inhibitors of protein synthesis and RNA synthesis prevent neural cell death caused by nerve growth factor deprivation. J Cell Biol 106:829-844
31. Koury MJ, Bondurant MC 1990 Erythropoitin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248:378-381
32. Nieto MA, Lopez-Rivas A 1989 IL-2 protects T lymphocytes from glucocorticoid-induced DNA fragmentation and cell death. J Immunol 143:4166-4170
33. Colotta, F, Polentarutti N, Sironi M, Mantovani A 1992 Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 267:18278-18283
34. Askew DS, Ashmun RA, Simmons BC, Cleveland JL 1991 Constituve c-myc expression in an IL-3-dependent myeloid cell line suppress cell cycle arrest and accelerate apoptosis. Oncogene 6:1915-1922
35. Gottlieb E, Haffner R, Ruden TV, Wagner EF, Oren M 1994 Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoitic cells following IL-3 withdrawal. EMBO J 13:1368-1374
36. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR 1990 Haemopoietic colony stimulating factors promote cell survival by suppresing apoptosis. Nature 343:76-79
37. Rittmaster RS, Manning AP, Wright AS, Thomas LN, Whitefield S, Norman RW, Lazier CB, Rowden G 1995 Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5α-reductase inhibitor finasteride. Endocrinology 136:741-748
38. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K, Yonehara S 1994 Anti-Fas on nonhematopoitic tumors: Levels of Fas/APO-1 and Bcl-2 are not predictive of biological responsiveness. Cancer Res 54:1580-1586
39. Suda T, Takahashi T, Golstein P, Nagata S 1993 Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178
40. Brunner T, Mogil RJ, La Face D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR 1995 Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridoma. Nature 373:441-444
41. Ju ST, Panka DJ, Cui H, Ettinger R, EI-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A 1995 Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448
42. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S 1995 Expression of the Fas ligand in cells of T cell lineage. J Immunol 154:3806-3813